Tissue engineered biografts for repair of damaged myocardium
Patent Number: 7,214,371
Date of First Priority Issue: Friday September 1st, 2000
Date Issued: Tuesday May 8th, 2007
Assignee: Ben-Gurion University of the Negev Research & Development Authority (Beer-Sheva, IL)
Inventors: Cohen; Smadar (Beer Sheva, IL), Dar; Ayelet (Rehovot, IL), Etzion; Sharon (Beer Shevea, IL), Perets; Anat (Bet-Shemesh, IL), Shaprut; Sigalit (Beer Sheva, IL), Leor; Jonathan (Gane' Tikva, IL)
From Class: 3D Culture/Scaffold
Comments: No comments
This patent covers various matrices that are seeded with cells in vitro and implanted in vivo into myocardial tissue so as to allow regeneration or healing. The patent uses a porous polysaccharide composition for shaping the matrics since it allows optimal cell viability and differentiation in vitro.
The patent also covers embedding of various growth factors and cytokines in the matrix so as to allow for sustained release and repair after implantation.
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday May 13th, 2007
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.